Webinar – LONG COVID: WHAT NEEDS TO HAPPEN NEXT? (5 & 6 July 2023)
NIHR Clinical Research Network in collaboration with Long Covid Support & Long Covid Scotland will hold a two-day Long COVID Webinar: Long COVID: What needs…
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial
New relevant publication on The Lancet! “An inhaled Covid vaccine booster was more than 5-fold effective for inducing…
Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies
Interesting literature review published by The Lancet with an analysis of studies that looked for the persistence of SARS-CoV-2 RNA…
Long COVID: The impact on language and cognition
The new article by Professor Louise Cummings (Department of English and Communication, The Hong Kong Polytechnic University) examines in…
Fighting Post-COVID and ME/CFS – development of curative therapies
Currently, there are no curative therapies for Post-COVID or ME/CFS. A German study led by Charité – Universitätsmedizin Berlin proposes the evaluation…
2nd Long COVID Press Release
On the occasion of its first year of implementation, the Long COVID project just launched a new Press…
Natural history of long-COVID in a nationwide, population cohort study
Very interesting article published by Nature Communication on the natural history of the Long COVID in Scotland Study…
What’s New in the Search for a Long COVID Cure?
Very interesting interview with University of California San Francisco infectious disease specialist Michael Peluso, who co-leads one of…